December, 2023
December 2023
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
28/10/2023 15:53

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10

Our 2023 OncoDaily series on ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023’ has been drawing to a close. Each week, we’ve highlighted 10 exceptional women leaders from around the globe who are advancing the field of oncology.

You can view the profiles of the nominees from the last weeks by checking out the links below:

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (1-10)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (11-20)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (21-30)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (31-40)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (41-50)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (51-60)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (61-70)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (71-80)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023 (81-90)

Below, we present the final installment of our 2023 list featuring 100 Women Leaders in Oncology. You can follow them on Twitter (X) and/or LinkedIn. While there are thousands of exceptional women leaders in oncology deserving of recognition, we regret that we couldn’t include everyone. However, this is just the beginning. We’re eager to hear your nominations for 2024, and we’ll share the submission link soon.

Dr. Julie Vose is the Neumann M. and Mildred E. Harris Professor and Chief in the Division of Oncology/Hematology at University of Nebraska Medical Center (UNMC). Dr. Vose was the 2015-16 President of the American Society of Clinical Oncology (ASCO).  In addition to that, she also served on the ASCO Board of Directors, Special Awards Selection, Nominating, and Scientific Program Committees, Health Disparities Committee, Hematology-Oncology Task Force, Cancer.Net Advisory Panel and Editorial Board, and Journal of Clinical Oncology Editorial Board. She also served as Chair of the Cancer Education Committee and Publications Committee. Dr. Vose was Co-Chair of the Lymphoma Steering Committee for the National Cancer Institute and has served on the U.S. Food and Drug Administration (FDA) Biologics Committee and the FDA Oncologic Drugs Advisory Committee (ODAC). She also served as Education Committee Chair for the American Society of Hematology and Education Committee Chair for the American Society of Bone Marrow Transplantation. In addition, Dr. Vose served as Journal Editor of Leukemia and Lymphoma, is on three additional editorial boards, and is a reviewer for 10 journals.

Follow Dr. Vose on X (Twitter) and LinkedIn.

Kathi Apostolidis is the Past President and Scientific Committee Chair of the European Cancer Patient Coalition, the largest European cancer patients’ organization, representing 347 associations in 47 EU and non-EU countries. As a twice breast cancer survivor, she was involved in breast cancer and cancer patient rights advocacy since 1995. She advocates for affordable, state-of-the-art cancer care, new therapies and cancer research.  She represents ECPC at the EMA’s Patients and Consumers Working Group, she is member of the European Commission Expert Group on Cancer Control, participates as ECPC representative in Work Packages of the EU Joint Action on Cancer Control (CanCon). She is a member of the Cancer Patients Working Group of ESMO, of the Steering Committee of HTAi’s Patients and Citizens Involvement Sub-Group.  At the national level, she is the founding member and President of the Hellenic Cancer Coalition-ELLOK, Chair of the Intergroup Committee for Cancer Patient Rights Advocacy/Greece (DEDIDIKA), a body linking 28 cancer patient organizations, she serves as a Deputy Board Member at KEFI-Association of Cancer Patients, Volunteers and Physicians/Greece, and is also member of other Greek & international cancer patient associations.

Follow Kathi Apostolidis on X (Twitter) and LinkedIn.

Dr. Deanna J. Attai is an Associate Clinical Professor of Surgery at the David Geffen School of Medicine at the University of California Los Angeles. Dr. Attai is a Past-President of the American Society of Breast Surgeons and a Fellow of the American College of Surgeons. Dr. Attai was an early adopter of social media for professional and patient education and has served as the social media editor for the Journal of Oncology Practice and the Annals of Surgical Oncology, as well as a member of the American Society of Clinical Oncology Social Media Working Group. She is also a founding member and former co-chair of the Collaborative for Outcomes in Social Media in Oncology research group. She has been an invited speaker at national meetings hosted by the American College of Surgeons, the American Society of Breast Surgeons, the American Medical Association, and the Association of Academic Surgeons discussing the use of social media for patient education and support, professional education and oncology research. Dr. Attai served as co-moderator for the weekly Breast Cancer Social Media (#BCSM) Twitter chats from 2011 – 2022. #BCSM was the first cancer patient community on Twitter, and has received national media attention with profiles in USA Today, CURE Magazine, Forbes Online, and Medscape.

Follow Dr. Attai on X (Twitter) and LinkedIn.

Janet Freeman-Daily is a freelance writer, speaker, retired aerospace systems engineer, and a metastatic lung cancer patient and advocate. Diagnosed in 2011, her focus is now on translating the experience and science of lung cancer for others. Janet is active on social media with her own blogspot, Gray Connections (, and is a moderator of Lung Cancer Social Media (#LCSM) chat on X(Twitter), promoting ePatient self-advocacy. She serves as a research advocate for two NCCN facilities, the NCI and other government agencies, and as an Editorial Group member for the IASLC (International Association for the Study of Lung Cancer) Lung Cancer News. Janet is the Co-Founder, President and Board Chair of The ROS1ders, Inc, a group of engaged patients and caregivers dealing with ROS1-positive cancer of all types. In 2015, Janet Freeman-Daily was named LUNGevity Hero for her incredible work in oncology.

Follow Janet Freeman-Daily on X (Twitter) and LinkedIn.

Dr. Cigall Kadoch is an Associate Professor of Pediatric Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, Affiliate Faculty of Biological Chemistry and Molecular Biology at Harvard Medical School, and Institute Member and Epigenomics Program Co-Director at the Broad Institute of MIT and Harvard. She established her independent laboratory in 2014, at age 28, one of the youngest scientists ever appointed to the Harvard Medical School faculty, immediately following completion of her Ph.D. studies in Cancer Biology at Stanford University. In 2016, Kadoch’s research resulted in the formation of Foghorn Therapeutics, a biotechnology company that seeks to build novel therapeutic strategies based on the chromatin regulatory system. Dr. Kadoch has received numerous prestigious awards and research grants to support her academic laboratory at Harvard, including the NIH Director’s New Innovator Award, the Pew Scholar Award, the American Cancer Society Research Scholar Award, the American Association for the Advancement of Sciences (AAAS) Marin and Rose Wachtel Cancer Research Prize, and the American Association for Cancer Research (AACR) Outstanding Achievement in Basic Cancer Research Award. Additionally, over the past several years, she was named to the Forbes 30 under 30 list, MIT Technology Review 35 Innovators Under 35, Popular Science Brilliant 10, Business Insider Top 30 Young leaders in Biopharma and was recently named a Blavatnik National Awards Finalist.

Follow Dr. Kadoch on X (Twitter) and LinkedIn.

Dr. Johanna Joyce is a Professor at the University of Lausanne, Switzerland, and Full Member of the international Ludwig Institute for Cancer Research. Prior to relocating her lab to Switzerland in 2016, she was a Full Member at Memorial Sloan Kettering Cancer Center and a Full Professor at Weill Cornell Medical School in New York. Johanna has been recognized for her contributions to cancer research through a series of awards including the Robert Bing Prize, Cloetta Prize, Metastasis Research Society Innovation Award, Swiss Bridge Award, American Cancer Society Scholar Award, Rita Allen Foundation Award, V Foundation Award, Sidney Kimmel Foundation Award, Fidler Innovation in Research Award, among many others. In 2017, she was elected as a Member of EMBO and a Fellow of the European Academy of Cancer Sciences, and in 2020 she was elected to the Women in Cancer Research Council of the AACR. Johanna currently serves on the advisory boards of the CRUK Cambridge Institute and Cancer Center, Cambridge, UK; the IRB Institute, Barcelona, Spain; the Robert Bosch Center for Tumor Diseases, Stuttgart, Germany; the Institute for Research in Biomedicine, Bellinzona, Switzerland; and on the editorial boards of Science, Cancer Cell, Cancer Discovery, The Journal of Experimental Medicine, and Trends in Cancer.

Follow Dr. Joyce on X (Twitter) and LinkedIn.

Dr. Nicole M. Kuderer is a medical oncologist at the Division of Hematology of the University of Washington Medical Center. She is the Deputy Editor of the Cancer Investigation Journal, Chief Medical Officer of the Advanced Cancer Research Group, Fellow of the American Society of Clinical Oncology (FASCO). She received her medical degree from Albany Medical College, completed Internal Medicine residency at the University of Rochester, fellowship in hematology and medical oncology at the Duke University Hospital and has been in practice for more than 20 years.

Follow Dr. Kuderer on X (Twitter) and LinkedIn.

Dr. Sara Cerdas is a Portuguese medical doctor and, since July of 2019, a Member of the European Parliament. She is a member of the Committee on the Environment, Public Health and Food Safety (ENVI), the Committee on Transport and Tourism (TRAN) and the Special Committee on COVID-19 (COVI). Sara Cerdas is the co-chair of the European Parliament’s Working Group on Health, which brings to discussion European health issues with different stakeholders and experts. She was vice-president of the Special Committee on Beating Cancer (BECA). Sara was shadow rapporteur for the S&D group on the European Health Program “EU4Health” and on the regulation on serious cross-border threats to health and was recently appointed shadow rapporteur by the S&D group for the regulation that will create the European Health Data Space. She holds a master’s degree in Medicine from the University of Lisbon, a postgraduate degree in traveler’s medicine from NOVA University Lisbon, a master’s degree in Public Health from the Umeå University and is a doctoral student in Public Health Sciences at the University of Stockholm.

Follow Dr. Cerdas on X (Twitter) and LinkedIn.

Deanna van Gestel is the founder and CEO of Women Leaders in Oncology, providing networking and mentorship opportunities to women in oncology field. She has 30 years of pharmaceutical industry experience, the last 25 in oncology. Deanna is the founder and CEO of the Vaniam Group, board member of the Conquer Cancer Foundation of the ASCO, a member of the Women Who Conquer Cancer Committee, and a member of the Tugboat Institute.

Follow Deanna van Gestel on X (Twitter) and LinkedIn.

Dr. Jill Biden is the First Lady of the United States, a community college educator and cancer advocate. Dr. Biden also served as Second Lady of the United States from 2009–2017. After Dr. Biden and then-Vice President Joe Biden lost their son Beau to brain cancer in 2015, they helped push for a national commitment to ending cancer – White House Cancer Moonshot. Following the Obama-Biden Administration, then-former Vice President Biden and Dr. Biden continued their cancer work through the Biden Cancer Initiative. Dr. Biden’s New York Times bestselling memoir, Where the Light Enters: Building a Family, Discovering Myself was published in 2019. Her second children’s book, JOEY: The Story of Joe Biden, was published in 2020. In recognition of World Cancer Day 2022, the President and First Lady reignited the Cancer Moonshot, laying out bold goals and a vision to end cancer.  As First Lady, Dr. Biden has focused on supporting patients and their loved ones during their cancer journeys; advocating for cancer screenings; and reducing health inequities in diagnosis, treatment, research, and outcomes.

Follow Dr. Biden on X (Twitter).